Mucosal Vaccines

Modern Concepts, Strategies, and Challenges

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology
Cover of the book Mucosal Vaccines by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642236938
Publisher: Springer Berlin Heidelberg Publication: January 11, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642236938
Publisher: Springer Berlin Heidelberg
Publication: January 11, 2012
Imprint: Springer
Language: English

This volume is focused on the development of vaccines which generate immune effectors capable of blocking mucosal entry or peripheral pathogen spread. A critical first step in the design of mucosal vaccines is the selection of administration route. Not all mucosal immunization routes are created equally when it comes to eliciting immune responses in multiple body compartments. This subject and situations when a mucosal route may not be required for vaccine delivery are reviewed here with an emphasis on the sublingual immunization route, which may offer a safer alternative to the nasal route for induction of broadly disseminated immune responses. External host defenses that inhibit entry of microorganisms at mucosal surfaces also pose obstacles to the efficient internalization of mucosally-applied vaccines. Transcutaneous immunization with appropriate adjuvants and permeation enhancers can induce mucosal immune responses and may be advantageous for bypassing these luminal barriers. Other chapters describe strategies for enhancing uptake of mucosal vaccines, for instance through targeted delivery to antigen-sampling M cells, construction of virus-like particles which mimic natural pathogens, addition of mucoadhesives or formulation as nanoparticles. Topics include edible vaccines as well as plant-based production of subunit or particulate vaccines that could be administered by any route. Dry powder vaccines that could be insufflated or directly applied to mucosal surfaces may be particularly ideal for mass vaccination in developing countries. The manufacture, stability and efficacy of powder formulations is comprehensively reviewed. We conclude with chapters on two of the greatest challenges facing mucosal vaccine development: human immunodeficiency virus and bioterrorist agents. This monograph highlights progress and information that should prove invaluable for the development of contemporary vaccines that prevent infection by these and other mucosal pathogens.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This volume is focused on the development of vaccines which generate immune effectors capable of blocking mucosal entry or peripheral pathogen spread. A critical first step in the design of mucosal vaccines is the selection of administration route. Not all mucosal immunization routes are created equally when it comes to eliciting immune responses in multiple body compartments. This subject and situations when a mucosal route may not be required for vaccine delivery are reviewed here with an emphasis on the sublingual immunization route, which may offer a safer alternative to the nasal route for induction of broadly disseminated immune responses. External host defenses that inhibit entry of microorganisms at mucosal surfaces also pose obstacles to the efficient internalization of mucosally-applied vaccines. Transcutaneous immunization with appropriate adjuvants and permeation enhancers can induce mucosal immune responses and may be advantageous for bypassing these luminal barriers. Other chapters describe strategies for enhancing uptake of mucosal vaccines, for instance through targeted delivery to antigen-sampling M cells, construction of virus-like particles which mimic natural pathogens, addition of mucoadhesives or formulation as nanoparticles. Topics include edible vaccines as well as plant-based production of subunit or particulate vaccines that could be administered by any route. Dry powder vaccines that could be insufflated or directly applied to mucosal surfaces may be particularly ideal for mass vaccination in developing countries. The manufacture, stability and efficacy of powder formulations is comprehensively reviewed. We conclude with chapters on two of the greatest challenges facing mucosal vaccine development: human immunodeficiency virus and bioterrorist agents. This monograph highlights progress and information that should prove invaluable for the development of contemporary vaccines that prevent infection by these and other mucosal pathogens.

More books from Springer Berlin Heidelberg

Cover of the book Leitfaden zur medizinischen Trainingsberatung by
Cover of the book Blind Source Separation by
Cover of the book Pearls of Glaucoma Management by
Cover of the book Biokraftstoffe und Biokraftstoffprojekte by
Cover of the book Myocardial Infarction and Psychosocial Risks by
Cover of the book Bauunternehmensmanagement-prozessorientiert Band 1 by
Cover of the book Der Mensch - Evolution, Natur und Kultur by
Cover of the book Pharma-Einkauf by
Cover of the book Stellar Disk Evolution and Gaseous Disk Turbulence of Dwarf Irregular Galaxies by
Cover of the book Advances in CT II by
Cover of the book Language Processing with Perl and Prolog by
Cover of the book Geschichte der Chemie Band 1 – Altertum, Mittelalter, 16. bis 18. Jahrhundert by
Cover of the book Moderne mathematische Methoden der Physik by
Cover of the book Atlas of Enteroscopy by
Cover of the book Electrochemical Analysis of Proteins and Cells by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy